Global Blood Therapeutics, Inc. (GBT) Earning

NASDAQ Currency in USD Disclaimer

$68.49

north_east NA Past Year
Day's range
$68.47
Day's range
$68.49

Global Blood Therapeutics, Inc. Earnings History by Quarter

Date Quarter Consensus Estimate Reported EPS Beat/Miss Revenue Estimate Actual Revenue
08/08/2022 Q2 2022 -$1.18 -$1.26 -0.08 N/A $71.55 M
05/04/2022 Q1 2022 -$1.30 -$1.26 0.04 N/A $55.16 M
02/23/2022 Q4 2021 -$1.13 -$1.42 -0.29 N/A $56.10 M
11/04/2021 Q3 2021 -$1.11 -$1.13 -0.02 N/A $52.05 M
08/03/2021 Q2 2021 -$1.19 -$1.12 0.07 N/A $47.56 M
05/05/2021 Q1 2021 -$1.01 -$1.21 -0.2 N/A $39.04 M
02/24/2021 Q4 2020 -$0.94 -$1.00 -0.06 N/A $41.30 M
11/05/2020 Q3 2020 -$0.76 -$0.97 -0.21 N/A $36.89 M
08/05/2020 Q2 2020 -$1.15 -$0.86 0.29 N/A $31.50 M
05/06/2020 Q1 2020 -$1.51 -$1.20 0.31 N/A $14.12 M
02/26/2020 Q4 2019 -$1.24 -$1.59 -0.35 N/A $2.11 M
11/07/2019 Q3 2019 -$1.05 -$1.07 -0.02 N/A $0
08/07/2019 Q2 2019 -$0.96 -$1.01 -0.05 N/A $0
05/09/2019 Q1 2019 N/A -$0.87 N/A N/A $0
02/27/2019 Q4 2018 -$0.89 -$0.93 -0.04 N/A $0
11/06/2018 Q3 2018 -$0.86 -$0.83 0.03 N/A $0
08/02/2018 Q2 2018 -$0.88 -$0.78 0.1 N/A $0
05/07/2018 Q1 2018 -$0.91 -$0.87 0.04 N/A $0
02/27/2018 Q4 2017 -$0.71 -$0.94 -0.23 N/A $0
11/02/2017 Q3 2017 -$0.61 -$0.66 -0.05 N/A $0

Global Blood Therapeutics, Inc. Earnings: FAQ's

Global Blood Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 3rd, 2022 based offlast year's report dates.

The conference call for Global Blood Therapeutics, Inc.'s latest earnings report can be listened to online.

The conference call transcript for Global Blood Therapeutics, Inc.'s latest earnings report can be read online.

Global Blood Therapeutics, Inc. (:GBT) has a recorded annual revenue of $194.75 M.

Global Blood Therapeutics, Inc. (:GBT) has a recorded net income of $-303,091,000.Global Blood Therapeutics, Inc. has generated $-4.82 earnings per share over the last four quarters.

Global Blood Therapeutics, Inc. (:GBT) has a price-to-earnings ratio of -14.22 and price/earnings-to-growth ratio is -0.14.

Portfolio Sync
Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED